Tags

Type your tag names separated by a space and hit enter

Neurological manifestations in coronavirus disease 2019.
Gac Med Mex. 2020; 156(4):317-320.GM

Abstract

Coronavirus disease 2019 (COVID-19), an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently hitting the world in the form of a pandemic. Given that some reports suggest that this infection can also occur with neurologic manifestations, this narrative review addresses the basic and clinical aspects concerning the nervous system involvement associated with this disease. More than one third of patients hospitalized for COVID-19 can present with both central and peripheral neurological manifestations. The former include dizziness and headache, while the latter include taste and smell disturbances. Other reported neurological manifestations are cerebrovascular disease and epileptic seizures. According to published reports, neurological disorders are not uncommon in COVID-19 and can sometimes represent the first manifestation of the disease; therefore, neurologists should consider this diagnostic possibility in their daily practice. Since maybe not all COVID-19 neurological manifestations are due to SARS-CoV-2 direct effects, it is important to monitor the rest of the clinical parameters such as, for example, oxygen saturation. Similarly, follow-up of patients is advisable, since whether neurological complications may develop lately is thus far unknown.

Authors+Show Affiliations

Academia Nacional de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México. Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Ciudad de México, México.Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Ciudad de México, México. Laboratorio Clínico de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez". Ciudad de México, México.Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, Ciudad de México, México. Laboratorio Clínico de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez". Ciudad de México, México.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32831319

Citation

Corona, Teresita, et al. "Neurological Manifestations in Coronavirus Disease 2019." Gaceta Medica De Mexico, vol. 156, no. 4, 2020, pp. 317-320.
Corona T, Rodríguez-Violante M, Delgado-García G. Neurological manifestations in coronavirus disease 2019. Gac Med Mex. 2020;156(4):317-320.
Corona, T., Rodríguez-Violante, M., & Delgado-García, G. (2020). Neurological manifestations in coronavirus disease 2019. Gaceta Medica De Mexico, 156(4), 317-320. https://doi.org/10.24875/GMM.20000195
Corona T, Rodríguez-Violante M, Delgado-García G. Neurological Manifestations in Coronavirus Disease 2019. Gac Med Mex. 2020;156(4):317-320. PubMed PMID: 32831319.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neurological manifestations in coronavirus disease 2019. AU - Corona,Teresita, AU - Rodríguez-Violante,Mayela, AU - Delgado-García,Guillermo, PY - 2020/8/25/entrez PY - 2020/8/25/pubmed PY - 2020/9/8/medline KW - COVID-19 KW - Coronavirus KW - Diseases of the nervous system KW - Enfermedades del sistema nervioso KW - Manifestaciones neurológicas KW - Neurological manifestations KW - Neurology KW - Neurología SP - 317 EP - 320 JF - Gaceta medica de Mexico JO - Gac Med Mex VL - 156 IS - 4 N2 - Coronavirus disease 2019 (COVID-19), an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently hitting the world in the form of a pandemic. Given that some reports suggest that this infection can also occur with neurologic manifestations, this narrative review addresses the basic and clinical aspects concerning the nervous system involvement associated with this disease. More than one third of patients hospitalized for COVID-19 can present with both central and peripheral neurological manifestations. The former include dizziness and headache, while the latter include taste and smell disturbances. Other reported neurological manifestations are cerebrovascular disease and epileptic seizures. According to published reports, neurological disorders are not uncommon in COVID-19 and can sometimes represent the first manifestation of the disease; therefore, neurologists should consider this diagnostic possibility in their daily practice. Since maybe not all COVID-19 neurological manifestations are due to SARS-CoV-2 direct effects, it is important to monitor the rest of the clinical parameters such as, for example, oxygen saturation. Similarly, follow-up of patients is advisable, since whether neurological complications may develop lately is thus far unknown. SN - 0016-3813 UR - https://www.unboundmedicine.com/medline/citation/32831319/Neurological_manifestations_in_coronavirus_disease_2019_ L2 - https://medlineplus.gov/coronavirusinfections.html DB - PRIME DP - Unbound Medicine ER -